← Eichor
Condition: Solid Tumor Childhood Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Solid Tumor Childhood

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CREATE: Art for Children With Cancer
NA · 1 location(s) · OHSU Knight Cancer Institute · NCT06342453Quality of End-of-Life Care for Children With Cancer
Phase N/A · 15 location(s) · Children's Oncology Group · NCT07412002Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SG
Phase 1 · 1 location(s) · Washington University School of Medicine · NCT05521984Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT00900471Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Phase 2 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07724756Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Phase 1/Phase 2 · 2 location(s) · St. Jude Children's Research Hospital · NCT05468359Development and Application of Intervention Program to Improve Mental Health and Quality of Life of Solid Tumor Survivor
NA · 3 location(s) · National Cancer Center, Korea · NCT06969742Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Phase 1/Phase 2 · 14 location(s) · Australian & New Zealand Children's Haematology/Oncology Gro · NCT06208657Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Soli
Phase 1/Phase 2 · 21 location(s) · Children's Oncology Group · NCT06620302Biomarkers of Resiliency In Childhood Cancer Surgery
Phase N/A · 1 location(s) · Mayo Clinic · NCT06674811A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in H
Phase 2 · 77 location(s) · Children's Oncology Group · NCT06410209Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Phase 1 · 1 location(s) · Florida International University · NCT05857969Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/Phase 2 · 10 location(s) · St. Jude Children's Research Hospital · NCT04901702Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Phase 1 · 2 location(s) · National Cancer Institute (NCI) · NCT04222413UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors
Phase 1 · 1 location(s) · Sun Yat-sen University · NCT06760117Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
Phase N/A · 3 location(s) · National Cancer Institute (NCI) · NCT03739827Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric P
Phase 1 · 5 location(s) · ITM Solucin GmbH · NCT06441331NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rar
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT07489378Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
Phase 1/Phase 2 · 4 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT03465592An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematol
NA · 1 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT05481502Liquid Biopsies in Pediatric Solid Tumors
Phase N/A · 1 location(s) · Children's Hospital Los Angeles · NCT05068583Precision Medicine for Every Child With Cancer
Phase N/A · 11 location(s) · Australian & New Zealand Children's Haematology/Oncology Gro · NCT05504772Project: Every Child for Younger Patients With Cancer
Phase N/A · 278 location(s) · Children's Oncology Group · NCT02402244B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT04897321Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents
Phase N/A · 1 location(s) · Institut Claudius Regaud · NCT05151718French Childhood Cancer Survivor Study
Phase N/A · 36 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT01620372Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compar
Phase 3 · 1 location(s) · Yizhuo Zhang · NCT06208917An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Phase 3 · 1 location(s) · Mayo Clinic · NCT06915727Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
NA · 1 location(s) · University of California, San Francisco · NCT05641961
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.